These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34378877)

  • 1. Monoaminergic hypo- or hyperfunction in adolescent and adult attention-deficit hyperactivity disorder?
    Nikolaus S; Mamlins E; Giesel FL; Schmitt D; Müller HW
    Rev Neurosci; 2022 Jun; 33(4):347-364. PubMed ID: 34378877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosted dopamine and blunted serotonin in Tourette syndrome - evidence from
    Nikolaus S; Mamlins E; Antke C; Dabir M; Müller HW; Giesel FL
    Rev Neurosci; 2022 Dec; 33(8):859-876. PubMed ID: 35575756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
    Ludolph AG; Kassubek J; Schmeck K; Glaser C; Wunderlich A; Buck AK; Reske SN; Fegert JM; Mottaghy FM
    Neuroimage; 2008 Jul; 41(3):718-27. PubMed ID: 18424180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.
    Nikolaus S; Antke C; Beu M; Müller HW
    Rev Neurosci; 2010; 21(2):119-39. PubMed ID: 20614802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
    da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R; Mulas F; Forssberg H
    Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
    Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for cortical dopamine in the paradoxical calming effects of psychostimulants.
    Harris SS; Green SM; Kumar M; Urs NM
    Sci Rep; 2022 Feb; 12(1):3129. PubMed ID: 35210489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D
    Gowrishankar R; Gresch PJ; Davis GL; Katamish RM; Riele JR; Stewart AM; Vaughan RA; Hahn MK; Blakely RD
    J Neurosci; 2018 Jun; 38(23):5302-5312. PubMed ID: 29739866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
    Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Brain Res; 1995 Apr; 676(2):343-51. PubMed ID: 7614004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.
    Hesse S; Ballaschke O; Barthel H; Sabri O
    Psychiatry Res; 2009 Feb; 171(2):120-8. PubMed ID: 19176281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.
    Frank MJ; Santamaria A; O'Reilly RC; Willcutt E
    Neuropsychopharmacology; 2007 Jul; 32(7):1583-99. PubMed ID: 17164816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.
    Chen Y; Zheng X; Xie L; Huang L; Ke Z; Zheng J; Lu H; Hu J
    Brain Res Bull; 2017 May; 131():214-220. PubMed ID: 28458039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.